Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-14

Clinical Trial Update: Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial update for a naltrexone and clonidine combination (ATNC05) in chronic back pain; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone and clonidine combination (ATNC05)

Snippet

Sponsor: Annette C. Toledano MD | Conditions: Back Pain, Lower Back Pain | Phase 2 | Status: COMPLETED